Monday, 6th February 2012
In Business In Japan,
Pharmaceuticals firm receives Japanese patent
Pharmaceuticals company Venus Remedies has been granted its first patent from the Japan Patent Office for its new research product Vancoplus.
The India-based company now plans to launch the Vancoplus, which is designed to fight bacterial resistance to MRSA, in early 2015.
Vancoplus works by restricting the efflux pump - which is the mechanism responsible for the extrusion of the toxic substances and antibiotics outside the cell. According to Venus Remedies, the drug is not only cost-effective but reduces treatment time.
Vancoplus is currently available in a number of emerging markets and Venus Remedies plans to licence the product to major pharmaceutical companies across patent-protected regions.
The company has been granted a patent from the US, South Africa, New Zealand and Ukraine.
Japan has a rising ageing population and high levels of expenditure on healthcare services. The country has the second largest per capita spending in the Asia Pacific region.
Written by Mark Smith